Cargando…
Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD
BACKGROUND: We evaluated Gamalate® B6 (GB6) in patients with borderline intellectual functioning (BIF) or mild intellectual development disability (IDD). PATIENTS AND METHODS: This was a prospective phase IV observational pilot study in 30 patients who underwent neuropsychological evaluation during...
Autores principales: | Novell, Ramón, Esteba-Castillo, Susanna, Rodriguez, Emili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048157/ https://www.ncbi.nlm.nih.gov/pubmed/32158489 http://dx.doi.org/10.7573/dic.212601 |
Ejemplares similares
-
The Pictorial Screening Memory Test (P-MIS) for Adults with Moderate Intellectual Disability and Alzheimer’s Disease
por: Rodríguez-Hidalgo, Emili, et al.
Publicado: (2022) -
The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer’s Disease
por: Rodríguez-Hidalgo, Emili, et al.
Publicado: (2023) -
Gamal Abdel Nasser
por: Terra Viera, Blanca
Publicado: (1965) -
High Incidence of Copy Number Variants in Adults with Intellectual Disability and Co-morbid Psychiatric Disorders
por: Viñas-Jornet, Marina, et al.
Publicado: (2018) -
Verbal Working Memory Processes in Students With Mild and Borderline Intellectual Disabilities: Differential Developmental Trajectories for Rehearsal and Redintegration
por: Bruns, Gunnar, et al.
Publicado: (2019)